Bibliographie (2530)
RCT: Effect of varenicline added to counseling on smoking cessation among African American daily smokers.
mercredi, 15 juin 2022 15:32 Écrit par Zouhair SouissiEffect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial – JAMA Network Open Editorial: Helping African American Individuals Quit Smoking: Finally, Some Progress – JAMA News Release: Varenicline Increases Smoking Cessation Rates for African American Smokers – University of Kansas Cancer […]
The post RCT: Effect of varenicline added to counseling on smoking cessation among African American daily smokers. appeared first on Links Medicus.
Cohort Study | Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration.
mercredi, 15 juin 2022 13:04 Écrit par Zouhair SouissiIntermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration – Critical Care
The post Cohort Study | Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration. appeared first on Links Medicus.
M-A: Treatment outcomes among pregnant patients with multidrug-resistant tuberculosis.
mercredi, 15 juin 2022 13:04 Écrit par Zouhair SouissiTreatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis – JAMA Network Open Commentary on Twitter This meta-analysis of pregnant patients treated for multi-drug-resistant tuberculosis (MDR-TB) found 73% treatment success and 73% favorable pregnancy outcomes, with adverse events (incl liver/kidney impairment, hearing loss) in more than half of patients. https://t.co/Mx5RLiwhU9 […]
The post M-A: Treatment outcomes among pregnant patients with multidrug-resistant tuberculosis. appeared first on Links Medicus.
![[Preprint] RCT: Ivermectin does not benefit patients with mild-to-moderate COVID-19 in the outpatient setting.](/media/k2/items/cache/473dc68f99076b0bcf5ab14122807f25_M.jpg)
[Preprint] RCT: Ivermectin does not benefit patients with mild-to-moderate COVID-19 in the outpatient setting.
mardi, 14 juin 2022 16:43 Écrit par Zouhair SouissiIvermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv Commentary: Study finds no benefit to taking ivermectin for COVID-19 symptoms – Duke University
The post [Preprint] RCT: Ivermectin does not benefit patients with mild-to-moderate COVID-19 in the outpatient setting. appeared first on Links Medicus.
Study among patients with sleep apnea showed multimorbidity was present in two-thirds of individuals at the time of diagnosis.
mardi, 14 juin 2022 16:43 Écrit par Zouhair SouissiMultimorbidity and overall comorbidity of sleep apnoea: a Finnish nationwide study – ERJ Open Research Commentary: Study Highlights Prevalence of OSA and Overall Burden of Comorbidities – AJMC Commentary on Twitter Two-thirds of individuals with sleep apnoea are multimorbid at diagnosis and one-third are heavily multimorbid. Dorsopathies, musculoskeletal diseases, hypertension and metabolic diseases are […]
The post Study among patients with sleep apnea showed multimorbidity was present in two-thirds of individuals at the time of diagnosis. appeared first on Links Medicus.
Systematic Review: Janus kinase inhibitors for the treatment of COVID‐19.
mardi, 14 juin 2022 16:43 Écrit par Zouhair SouissiJanus kinase inhibitors for the treatment of COVID‐19 – Cochrane Library Summary: Are systemic Janus kinase inhibitors an effective treatment for people with COVID-19? – Cochrane Library
The post Systematic Review: Janus kinase inhibitors for the treatment of COVID‐19. appeared first on Links Medicus.
NIH Updated Guideline: Oxygenation and ventilation for adults with Covid-19.
lundi, 13 juin 2022 17:50 Écrit par Zouhair SouissiOxygenation and Ventilation for Adults – National Institutes of Health
The post NIH Updated Guideline: Oxygenation and ventilation for adults with Covid-19. appeared first on Links Medicus.
M-A: Respiratory viral co-infections in patients with COVID-19 and associated outcomes.
lundi, 13 juin 2022 17:50 Écrit par Zouhair SouissiRespiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis – Reviews in Medical Virology
The post M-A: Respiratory viral co-infections in patients with COVID-19 and associated outcomes. appeared first on Links Medicus.
RCT: Intramuscular tixagevimab–cilgavimab may benefit non-hospitalized unvaccinated adults with Covid-19.
lundi, 13 juin 2022 17:50 Écrit par Zouhair SouissiEfficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Respiratory Medicine Commentaries: Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID – News Medical Expert reaction to results of the TACKLE Phase 3 trial of Evusheld (tixagevimab and cilgavimab) […]
The post RCT: Intramuscular tixagevimab–cilgavimab may benefit non-hospitalized unvaccinated adults with Covid-19. appeared first on Links Medicus.
Brief Review: How to manage anticoagulation during extracorporeal membrane oxygenation.
lundi, 13 juin 2022 12:39 Écrit par Zouhair SouissiHow to manage anticoagulation during extracorporeal membrane oxygenation – Intensive Care Medicine (if the link is paywalled, try this one) Related: 2021 ELSO Adult and Pediatric Anticoagulation Guidelines – ASAIO Journal
The post Brief Review: How to manage anticoagulation during extracorporeal membrane oxygenation. appeared first on Links Medicus.
![[Preprint] Largest study to date on long COVID identifies a broad list of diagnoses.](/media/k2/items/cache/c5cf324911483ffb68f0668461e12a5f_XS.jpg)
